EFFECT OF INVITRO CLEAVAGE OF APURINIC APYRIMIDINIC SITES ON BLEOMYCIN-INDUCED MUTAGENESIS OF REPACKAGED LAMBDA PHAGE

被引:25
作者
STEIGHNER, RJ [1 ]
POVIRK, LF [1 ]
机构
[1] VIRGINIA COMMONWEALTH UNIV,MED COLL VIRGINIA,DEPT PHARMACOL & TOXICOL,RICHMOND,VA 23298
来源
MUTATION RESEARCH | 1990年 / 240卷 / 02期
关键词
Apurinic/apyrimidinic sites; Bleomycin-induced mutagenesis; Endonuclease IV; Lambda phage; repackaged; Oxidative mutagens; Radiomimetic drugs;
D O I
10.1016/0165-1218(90)90012-Q
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Previous studies have revealed bleomycin to be a potent base-substitution mutagen in repackaged phage lambda. In order to assess the role of apurinic/apyrimidinic (AP) sites in bleomycin-induced mutagenesis, bleomycin-damaged lambda DNA was treated with putrescine or endonuclease IV to effect cleavage of bleomycin-induced AP sites. The DNA was then packaged, the phage grown in SOS-induced E. coli, and the frequency of clear-plaque mutants in the progeny was determined. Bleomycin-induced mutagenesis was decreased approx. 2-fold by treating the DNA with putrescine, but was unaffected by endonuclease IV. The results are consistent with the production of bleomycin-induced mutation at certain AP sites having a closely opposed single-strand break, since such sites are cleaved by putrescine but not by endonuclease IV. © 1990.
引用
收藏
页码:93 / 100
页数:8
相关论文
共 30 条
[1]  
BURNOTTE J, 1971, J BIOL CHEM, V264, P5914
[2]   EXONUCLEASE-III AND ENDONUCLEASE-IV REMOVE 3' BLOCKS FROM DNA-SYNTHESIS PRIMERS IN H2O2-DAMAGED ESCHERICHIA-COLI [J].
DEMPLE, B ;
JOHNSON, A ;
FUNG, D .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1986, 83 (20) :7731-7735
[3]   CROSSLINKING OF DEOXYRIBONUCLEIC ACID BY EXPOSURE TO LOW PH [J].
FREESE, E ;
CASHEL, M .
BIOCHIMICA ET BIOPHYSICA ACTA, 1964, 91 (01) :67-&
[4]  
GILONI L, 1981, J BIOL CHEM, V256, P8608
[5]  
HAIDLE CW, 1972, MOL PHARMACOL, V8, P531
[6]  
Horwitz SB, 1979, BLEOMYCIN CHEM BIOCH, P170
[7]  
HUTCHINSON F, 1977, MOL GEN GENET, V152, P19
[8]  
KUO MT, 1973, BIOCHIM BIOPHYS ACTA, V335, P109
[9]  
LLOYD RS, 1978, CANCER RES, V38, P3191
[10]   APURINIC SITES AS MUTAGENIC INTERMEDIATES [J].
LOEB, LA .
CELL, 1985, 40 (03) :483-484